REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
06/08/2026
Back to search
Official data from USPTO
PHARMCUBE
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
PHARMCUBE
ST13
US500000088502684Class
35, 36, 38
Filing
88502684
Registration
6375538
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
31
Latest update
06/09/2026
Trademark type
Word
Nice classes
35, 36, 38
Filing date
07/07/2019
Registration date
06/08/2021
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
06/08/2021
Last transaction
06/09/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
16
Owner location
SHANGHAI, CN
Examiner
SIRIGNANO, EMMA MARIE
Law office
M40
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
PHARMCUBE GROUP CO., LTD.
PHARMCUBE (BEIJING) CO., LTD.
Beijing Pharmcube Technology Limited
Representatives
Gloria Tsui-Yip Gottlieb, Rackman & Reisman, P.C.
Technical classification
Nice Classes
Class 35Class 36Class 38
Vienna Codes
No Vienna codes available.
Goods and services
Class 35
Providing an on-line database via website that features business intelligence in the fields of medical devicespharmaceuticals and life sciences
Class 36
Investment consultation in the field of medical devicespharmaceuticalshealth care and life sciences; Financial investment brokerage services in the field of medical devicespharmaceuticalshealth care and life sciences; Financial information provided by electronic means in the field of medical devicespharmaceuticals and life sciences; Fund investment consultation in the field of medical devicespharmaceuticalshealth care and life sciences; Mutual fund investment in the field of medical devicespharmaceuticalshealth care and life sciences; mutual funds and capital investment in the field of medical devicespharmaceuticalshealth care and life sciences
Class 38
Providing an on-line forum for medical devicespharmaceuticals and life sciences
Publications
History of USPTO decisions and trademark events.
31 publications found
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
09/05/2024
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
05/19/2022
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
02/08/2022
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
02/08/2022
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
02/08/2022
R.PR
REGISTERED-PRINCIPAL REGISTER
06/08/2021
CHPB
POST PUBLICATION AMENDMENT - ENTERED
05/06/2021
APET
ASSIGNED TO PETITION STAFF
05/06/2021
ETOP
EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
03/21/2021
EPPA
TEAS POST PUBLICATION AMENDMENT RECEIVED
02/10/2021
ETOF
EXTENSION OF TIME TO OPPOSE RECEIVED
12/10/2020
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
11/10/2020
PUBO
PUBLISHED FOR OPPOSITION
11/10/2020
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
10/21/2020
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
10/06/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
10/01/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
10/01/2020
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
10/01/2020
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
04/24/2020
GNRT
NON-FINAL ACTION E-MAILED
04/24/2020
CNRT
NON-FINAL ACTION WRITTEN
04/24/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
03/31/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
03/30/2020
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
03/30/2020
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
10/01/2019
GNRT
NON-FINAL ACTION E-MAILED
10/01/2019
CNRT
NON-FINAL ACTION WRITTEN
10/01/2019
DOCK
ASSIGNED TO EXAMINER
09/24/2019
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
07/15/2019
NWAP
NEW APPLICATION ENTERED
07/10/2019
Continuous trademark protection
Get notified about every new filing that threatens PHARMCUBE or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.